NEJM Catalyst

📢 In the June issue: public health misinformation, high-quality emergency care, deterioration response, chronic disease care, obesity care, cervical cancer screening, missed patient appointments, AI deployment, and patient storytelling. nej.md/4eVibUP 🧵👇

Call for papers (deadline June 1): Assessing Implementation and Impact of the 4Ms Framework to Advance Age-Friendly Health Systems — Special Theme Issue nej.md/4kNTpXw

This framework offers a starting point for health systems seeking to ensure that AI deployments remain safe and effective over time: nej.md/3PzjPB9

and the difficulty of incorporating data-driven monitoring practices into complex organizations where conflicting priorities and definitions of success often coexist.

🧵 Postdeployment monitoring of artificial intelligence (AI) systems in health care is essential to ensure their safety, quality, and sustained benefit — and to support governance decisions about which systems to update, modify, or decommission.

These findings suggest that the DETER program may represent a scalable model for improving patient safety and overall hospital performance: nej.md/4tHGUiY

Rapid response team activations increased from 6.7% in the control group to 10.2% in the intervention group (P<0.001), reflecting earlier clinical recognition and intervention.

🧵 Unrecognized physiologic deterioration is a persistent challenge across health care systems, resulting in missed opportunities for early intervention and reduced inpatient mortality. Early detection and structured response protocols may improve clinical outcomes.

HPV self-collect provides an opportunity to efficiently screen more people for cervical cancer and potentially increase primary care access: nej.md/4fwFlRr

Iterative sharing of evaluation goals and findings between researchers and health system leaders led to program improvements and identified further opportunities for strengthening implementation.

🧵 Virtually all cervical cancers are caused by high-risk human papillomaviruses (HPVs), which can be accurately detected using deoxyribonucleic acid (DNA) testing from cervical or vaginal samples.